Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Clinical trial NCT06397963 · RECRUITING

Trial details

NCT number: NCT06397963
Sponsor: Grit Biotechnology
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-04-18
Primary completion: 2027-04-18
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.